Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice
Shima Bastaki, A. Surendar, Nasrin Ahmadpour Saheb, et al.
Life Sciences (2020) Vol. 266, pp. 118847-118847
Closed Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Chitosan-based nanodelivery systems for cancer therapy: Recent advances
Asghar Narmani, Seid Mahdi Jafari
Carbohydrate Polymers (2021) Vol. 272, pp. 118464-118464
Closed Access | Times Cited: 134
Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy
Milad Ashrafizadeh, Masoud Delfi, Farid Hashemi, et al.
Carbohydrate Polymers (2021) Vol. 260, pp. 117809-117809
Closed Access | Times Cited: 133
Nanomedicine for brain cancer
Sabina Quader, Kazunori Kataoka, Horacio Cabral
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114115-114115
Open Access | Times Cited: 99
Engineering siRNA therapeutics: challenges and strategies
Syed Saqib Ali Zaidi, Faria Fatima, Syed Aqib Ali Zaidi, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 58
Functionalized chitosan for cancer nano drug delivery
Yazid Zaiki, Athirah Iskandar, Tin Wui Wong
Biotechnology Advances (2023) Vol. 67, pp. 108200-108200
Closed Access | Times Cited: 57
Unveiling the Power of Gabapentin-Loaded Nanoceria with Multiple Therapeutic Capabilities for the Treatment of Dry Eye Disease
Chia‐Jung Yang, Anisha Anand, Chih‐Ching Huang, et al.
ACS Nano (2023) Vol. 17, Iss. 24, pp. 25118-25135
Closed Access | Times Cited: 56
Recent Applications of Chitosan and Its Derivatives in Antibacterial, Anticancer, Wound Healing, and Tissue Engineering Fields
Saeid Mezail Mawazi, Mohit Kumar, Noraini Ahmad, et al.
Polymers (2024) Vol. 16, Iss. 10, pp. 1351-1351
Open Access | Times Cited: 43
Multi-functional chitosan-based nanoparticles for drug delivery: Recent advanced insight into cancer therapy
Bingren Tian, Shiyao Hua, Jiayue Liu
Carbohydrate Polymers (2023) Vol. 315, pp. 120972-120972
Closed Access | Times Cited: 42
Simultaneous blockade of the CD73/EGFR axis inhibits tumor growth
Keivan Ardeshiri, Hadi Hassannia, Ghasem Ghalamfarsa, et al.
IUBMB Life (2025) Vol. 77, Iss. 1
Closed Access | Times Cited: 1
Targeted delivery systems of siRNA based on ionizable lipid nanoparticles and cationic polymer vectors
Zhao Yao, Taiqing Liu, Jingwen Wang, et al.
Biotechnology Advances (2025) Vol. 81, pp. 108546-108546
Closed Access | Times Cited: 1
Chitosan: A versatile bio-platform for breast cancer theranostics
Vijay Sagar Madamsetty, Shima Tavakol, Saeid Moghassemi, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 733-752
Closed Access | Times Cited: 55
Functionalized chitosan as a promising platform for cancer immunotherapy: A review
Xiaoyan Liang, Min Mu, Rangrang Fan, et al.
Carbohydrate Polymers (2022) Vol. 290, pp. 119452-119452
Closed Access | Times Cited: 49
Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy
Seyed Hossein Kiaie, Hossein Salehi‐Shadkami, Mohammad‐Javad Sanaei, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 33
Nano-formulated siRNA-based therapeutic approaches for cancer therapy
Dolly Jain, Shiv Kumar Prajapati, Ankit Jain, et al.
Nano Trends (2023) Vol. 1, pp. 100006-100006
Open Access | Times Cited: 21
Oral delivery of RNAi for cancer therapy
Humayra Afrin, Renu Geetha Bai, Raj Kumar, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 699-724
Open Access | Times Cited: 21
Peptide‐conjugated Nanoparticle Platforms for Targeted Delivery, Imaging, and Biosensing Applications
Bogdan Dragoş Ilieş, İbrahim Yıldız, Muhammad Abbas
ChemBioChem (2024) Vol. 25, Iss. 10
Closed Access | Times Cited: 13
Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Courtney Clark, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1868, Iss. 3, pp. 166326-166326
Open Access | Times Cited: 53
A review of chitosan in gene therapy: Developments and challenges
Liang Dong, Yanan Li, Hailin Cong, et al.
Carbohydrate Polymers (2023) Vol. 324, pp. 121562-121562
Closed Access | Times Cited: 20
Alginate-Chitosan Biodegradable and Biocompatible Based Hydrogel for Breast Cancer Immunotherapy and Diagnosis: A Comprehensive Review
Pratikshya Patra, Tarun Kumar Upadhyay, Nawaf Alshammari, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 6, pp. 3515-3534
Open Access | Times Cited: 6
Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges
Xixi Wu, Xin Yuan, Hengtong Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7415-7471
Open Access | Times Cited: 5
Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli, et al.
Life Sciences (2021) Vol. 275, pp. 119369-119369
Closed Access | Times Cited: 36
Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo
Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Parisa Sahami Gilan, et al.
International Journal of Biological Macromolecules (2021) Vol. 186, pp. 849-863
Closed Access | Times Cited: 34
Recent Advancements in the Design of Nanodelivery Systems of siRNA for Cancer Therapy
Dokkari Nagalaxmi Yadav, Mohammad Sadik Ali, Ajinkya Madhukar Thanekar, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 12, pp. 4506-4526
Closed Access | Times Cited: 23
Integrated Nanorod‐Mediated PD‐L1 Downregulation in Combination with Oxidative‐Stress Immunogene Therapy against Cancer
Shuaiying Wu, Jianzhong Zhang, Jie Pan, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 17
Closed Access | Times Cited: 13
Chitosan nanocarriers for non-coding RNA therapeutics: A review
Karthik Siram, S. Mohan, Induja Magesh, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130361-130361
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top